Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

Back

ESC Premium Access

Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

Session: Biomarkers to improve prognostication in heart failure: what's new?

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor A. Reese-Petersen (Copenhagen, DK)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Alexander Lynge Reese-Petersen

Nordic Bioscience, Copenhagen (Denmark)

0 follower

4 more presentations in this session

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

Speaker: Doctor G. Vergaro (Pisa, IT)

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

Speaker: Doctor S. Kiddle (Cambridge, GB)

Cysteine-rich angiogenic inducer 61 (CCN1) independently predicts all-cause mortality in patients with dilated cardiomyopathy

Speaker: Doctor R. Klingenberg (Frankfurt am Main, DE)

Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure

Speaker: Doctor G. Vergaro (Pisa, IT)

Access the full session

Biomarkers to improve prognostication in heart failure: what's new?

Speakers: Doctor A. Reese-Petersen, Doctor G. Vergaro, Doctor S. Kiddle, Doctor R. Klingenberg, Doctor G. Vergaro

Access

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources